Bio-Gene Technology Limited (BGT.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 18.32 Thousand AUD | -96.92% |
| 2023 | 595.07 Thousand AUD | -32.36% |
| 2022 | 879.77 Thousand AUD | 53.51% |
| 2021 | 573.11 Thousand AUD | -36.85% |
| 2020 | 907.58 Thousand AUD | 78.39% |
| 2019 | 508.75 Thousand AUD | 47.7% |
| 2018 | 344.45 Thousand AUD | 5353.61% |
| 2017 | 6316.00 AUD | -96.61% |
| 2016 | 186.41 Thousand AUD | 0.0% |
| 2015 | - AUD | -100.0% |
| 2014 | 76.00 AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 18.75 Thousand AUD | 0.0% |
| 2024 FY | 18.32 Thousand AUD | -96.92% |
| 2024 Q4 | -435.00 AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 FY | 595.07 Thousand AUD | -32.36% |
| 2023 Q4 | 149.23 Thousand AUD | 0.0% |
| 2022 Q2 | 349.04 Thousand AUD | 0.0% |
| 2022 FY | 879.77 Thousand AUD | 53.51% |
| 2022 Q4 | 96.67 Thousand AUD | 0.0% |
| 2021 Q4 | 22.61 Thousand AUD | 0.0% |
| 2021 Q1 | 226.89 Thousand AUD | 84.78% |
| 2021 FY | 573.11 Thousand AUD | -36.85% |
| 2021 Q2 | 40 Thousand AUD | -82.37% |
| 2020 Q2 | 80 Thousand AUD | 0.0% |
| 2020 Q4 | 122.79 Thousand AUD | -45.88% |
| 2020 Q3 | 226.89 Thousand AUD | 183.62% |
| 2020 FY | 907.58 Thousand AUD | 78.39% |
| 2019 Q3 | 126.46 Thousand AUD | 61.7% |
| 2019 FY | 508.75 Thousand AUD | 47.7% |
| 2019 Q4 | 2899.00 AUD | -97.71% |
| 2019 Q2 | 78.21 Thousand AUD | 0.0% |
| 2018 Q4 | 428.98 Thousand AUD | 40659.05% |
| 2018 FY | 344.45 Thousand AUD | 5353.61% |
| 2018 Q2 | 45.53 Thousand AUD | 0.0% |
| 2018 Q3 | 1052.50 AUD | -97.69% |
| 2017 Q4 | 106.71 Thousand AUD | 0.0% |
| 2017 FY | 6316.00 AUD | -96.61% |
| 2017 Q2 | 10.00 AUD | 0.0% |
| 2016 FY | 186.41 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -100.0% |
| 2014 FY | 76.00 AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.972% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | 80.706% |
| Biome Australia Limited | 13 Million AUD | 99.859% |
| Patrys Limited | 1.39 Million AUD | 98.686% |
| Orthocell Limited | 5.31 Million AUD | 99.655% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | 2.4 Million AUD | 99.237% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.917% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 99.754% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 99.507% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 97.947% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 99.209% |
| CSL Limited | 22.41 Billion AUD | 100.0% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -7.765% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.979% |
| Starpharma Holdings Limited | 8.28 Million AUD | 99.779% |
| Nanollose Limited | 12.5 Thousand AUD | -46.548% |
| Memphasys Limited | 60 Thousand AUD | 69.467% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 98.489% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 99.589% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 96.956% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 98.536% |
| Race Oncology Limited | 4 Million AUD | 99.542% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.996% |
| Dimerix Limited | 583.47 Thousand AUD | 96.86% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 99.477% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.841% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 99.544% |
| BTC Health Limited | 16.36 Thousand AUD | -11.98% |
| Acrux Limited | 5.09 Million AUD | 99.64% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.992% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 152.24 Thousand AUD | 87.966% |
| AdAlta Limited | 1.73 Million AUD | 98.946% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 93.878% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 96.021% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 72.158% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | 96.131% |
| Actinogen Medical Limited | 9.93 Million AUD | 99.816% |
| Immuron Limited | 4.9 Million AUD | 99.626% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 99.295% |